Omega Says Bank's Rug-Pull Led Cash-Strapped Co. To Ch. 11
Biotechnology company Omega Therapeutics, which hit Chapter 11 this week with over $140 million of debt and a restructuring agreement, has said it became insolvent because a bank that gave it...To view the full article, register now.
Already a subscriber? Click here to view full article